AHA Releases Statement on Minimally Invasive Treatment of Diseased Brain Vessels
April 7, 2009 - The American Heart Association/American Stroke Association is providing recommendations for the use of minimally invasive procedures to treat brain blood vessel diseases.
The new statement is published in Circulation: Journal of the American Heart Association and addresses the use of stenting, coil embolization, in-artery delivery of clot busting drugs and mechanical clot-removing devices for the treatment of brain aneurysms, narrowed brain arteries, acute ischemic stroke and arteriovenous malformations (abnormal connections between arteries and veins).
Statement authors include: Philip M. Meyers, M.D., chair; H. Christian Schumacher, M.D., co-chair; Randall T. Higashida, M.D., co-chair; Stanley L. Barnwell, M.D., Ph.D.; Mark A. Creager, M.D.; Rishi Gupta, M.D.; Cameron G. McDougall, M.D.; Dilip K. Pandey, M.D.; David Sacks, M.D.; and Lawrence R. Wechsler, M.D.
For more information: http://circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.109.192217
More like this
- New Stoke Guidelines: Ultrasound Screening Not Needed in All Patients
- Set to Launch at HRS, New Coalition Will Urge Federal Government to Get Serious on Sudden Cardiac Arrest
- Carotid Angioplasty Recommended in Revised Recurrent Stroke Guidelines
- Surgery, Stenting of Carotids Similar in Safety, Efficacy
- AHA Offers Advice on Treating Deep Blood Clots